Cytiva News
-
GE Healthcare Launches New Modular Chromatography System For Protein Purification
9/5/2012
GE Healthcare launches the of ÄKTA™ pure, a chromatography system for flexible, reliable and intuitive purification of proteins with the flexibility to support both routine and challenging purification requirements, as well as being adaptable to changing research needs.
-
GE Healthcare launches modular biopharmaceutical factory, KUBio
9/4/2012
GE Healthcare, the healthcare business of GE, today introduced KUBio™, an innovative off-the-shelf, modular factory designed to save manufacturers of biopharmaceuticals both time and money. KUBio’s pre-made modules, which are assembled at a customer’s chosen site to make a fully functional ready-to-run bioprocessing facility, are significantly faster to install than constructing a traditional factory.
-
GE Healthcare Launches ÄKTA™ Pure, A New Modular Chromatography System For Protein Purification
8/24/2012
GE Healthcare, the healthcare business of GE announced recently the launch of ÄKTA™ pure, a chromatography system for flexible, reliable and intuitive purification of proteins.
-
GE Healthcare Launches Ni Sepharose Excel Chromatography Media For Direct Purification Of Histidine-Tagged Proteins Secreted From Eukaryotic Expression Systems
8/21/2012
GE Healthcare’s Ni Sepharose excel is an immobilized metal ion affinity chromatography (IMAC) medium (resin) for the direct capture and purification of secreted histidine-tagged recombinant proteins from eukaryotic cell culture supernatants.
-
GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility
8/1/2012
GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.
-
iBio, Inc. And GE Healthcare Form New Global Alliance
7/26/2012
iBio, Inc., and GE Healthcare, the healthcare business of GE, announced recently a new global alliance to commercialize plant-based technologies for the manufacture of biopharmaceuticals and vaccines.
-
Karolinska University Hospital And GE Healthcare Collaborate To Advance Technologies For Cell Therapy
5/22/2012
Karolinska University Hospital Sweden and GE Healthcare Life Sciences recently announced a joint research collaboration to drive advances in technologies and workflows for use in the rapidly emerging field of cell therapy.
-
GE Healthcare Life Sciences Launches Capto™ L Chromatography Medium For Capture Of Antibodies And Antibody Fragments
5/8/2012
GE Healthcare’s Capto L affinity chromatography medium (resin) is designed for the purification of antibody fragments. It combines a rigid, high-flow agarose matrix with the immunoglobulin-binding recombinant protein L ligand, which has strong affinity for the variable region of antibody’s kappa light chain.
-
GE Healthcare And BAC Collaborate To Launch New Bioprocess Affinity Resin
3/20/2012
GE Healthcare, the healthcare business of GE and BAC BV, the leading provider of antibody-based affinity purification technology, announced recently that, following a successful collaboration between the two companies, GE Healthcare Life Sciences has added a new and innovative affinity resin to its portfolio of technologies for the purification of antibody-based fragments.
-
GE Healthcare Launches Capto™ ImpRes Ion Exchangers For High Throughput And High Resolution Purification Of Recombinant Proteins
1/28/2011
Uppsala, Sweden – GE Healthcare, a unit of General Electric Company (NYSE: GE), announced today that the capabilities of the well-established Capto platform are now extended to include Capto ImpRes ion exchange chromatography media for late-stage purification of a wide range of biomolecules.